Biotech entity
All 1 tracked stories fall under one category: pharma. Healius is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Solvar appears in 1 tracked Biotech story from February 18, 2026. The tracked stories average 6 original sources each.
Last mentioned: Feb 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Healius is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Solvar appears in 1 tracked Biotech story from February 18, 2026. The tracked stories average 6 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Solvar. Shared-story counts are live from our verified record — not editorial picks.
Healius's H1 earnings call highlighted a strategic focus on operational efficiency and pathology volume recovery in a challenging macroeconomic environment. As the diagnostic giant navigates rising labor costs and inflationary pressures, its performance serves as a critical indicator for the broader Australian healthcare services sector.
Solvar is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
